Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease

Journal of Hepatology

Volumn 49, Issue 5, 2008, Pages 810-820

  Komatsu, Michiharu ^a   Yazaki, Masahide ^a   Tanaka, Naoki ^a,b   Sano, Kenji ^c   Hashimoto, Etsuko ^d   Takei, Yo ichi ^a   Song, Yuan Zong ^e   Tanaka, Eiji ^a   Kiyosawa, Kendo ^f   Saheki, Takeyori ^g   Aoyama, Toshifumi ^b   Kobayashi, Keiko ^e  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SHINSHU UNIVERSITY HOSPITAL   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e KAGOSHIMA UNIVERSITY   (Japan)

^f NAGANO RED CROSS HOSPITAL   (Japan)

^g TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

Adult onset type II citrullinemia; Body mass index; Non alcoholic fatty liver disease; Pancreatic secretory trypsin inhibitor

Indexed keywords

APROTININ; CALCIUM BINDING PROTEIN; ERIODICTYOL 7 O GLUCOSIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC LIVER DISEASE; CITRULLINEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; LABORATORY TEST; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL;

ADULT; AGED; CARRIER PROTEINS; CITRULLINEMIA; DIAGNOSIS, DIFFERENTIAL; FATTY LIVER; FEMALE; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; METABOLIC SYNDROME X; MIDDLE AGED; MITOCHONDRIAL PROTEINS; MODELS, BIOLOGICAL; MUTATION; OBESITY; YOUNG ADULT;

EID: 53249111691     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.05.016     Document Type: Article

References (42)

1. 2+-stimulated aspartate/glutamate transporters in mitochondria. EMBO J 20 (2001) 5060-5069
2. Saheki T., Kobayashi K., Iijima M., Moriyama M., Yazaki M., Takei Y., et al. Metabolic derangements in deficiency of citrin, a liver-type mitochondrial aspartate-glutamate carrier. Hepatol Res 33 (2005) 181-184
3. Saheki T., and Kobayashi K. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis. J Hum Genet 47 (2002) 333-341
4. Kobayashi K., Sinasac D.S., Iijima M., Boright A.P., Begum L., Lee J.R., et al. The gene mutated in adult-onset type II citrullinemia encodes a putative mitochondrial carrier protein. Nat Genet 22 (1999) 159-163
5. Kobayashi K., Lu Y.B., Li M.X., Nishi I., Hisao K.J., Choeh K., et al. Screening of nine SLC25A13 mutations: their frequency in patients with citrin deficiency and high carrier rates in Asian populations. Mol Genet Metab 80 (2003) 356-359
6. Lu Y.B., Kobayashi K., Ushiki M., Tabata A., Iijima M., Li M.X., et al. Frequency and distribution in East Asia of 12 mutations identified in the SLC25A13 gene of Japanese patients with citrin deficiency. J Hum Genet 50 (2005) 338-346
7. Ben-Shalom E., Kobayashi K., Shaag A., Yasuda T., Gao H.Z., Saheki T., et al. Infantile citrullinemia caused by citrin deficiency with increased dibasic amino acids. Mol Genet Metab 77 (2002) 202-208
8. Hutchin T., Preece M.A., Kobayashi K., Saheki T., Brown R., Kelly D.A., et al. Neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) in a European patient. J Inherit Metab Dis 29 (2006) 112
9. Dimmock D., Kobayashi K., Iijima M., Tabata A., Wong L.J., Saheki T., et al. Citrin deficiency: a novel cause of failure to thrive that responds to a high-protein, low-carbohydrate diet. Pediatrics 119 (2007) 773-777
10. Yazaki M., Takei Y., Kobayashi K., Saheki T., and Ikeda S. Risk of worsened encephalopathy after intravenous glycerol therapy in patients with adult-onset type II citrullinemia (CTLN2). Intern Med 44 (2005) 188-195
11. Takahashi H., Kagawa T., Kobayashi K., Hirabayashi H., Yui M., Begum L., et al. A case of adult-onset type II citrullinemia: deterioration of clinical course after infusion of hyperosmotic and high sugar solutions. Med Sci Monit 12 (2006) CS13-CS15
12. Saheki T., Iijima M., Li M.X., Kobayashi K., Horiuchi M., Ushikai M., et al. Citrin/mitochondrial glycerol 3-phosphate double-knockout mice recapitulate features of human citrin deficiency. J Biol Chem 282 (2007) 25041-25052
13. Tanaka N., Yazaki M., and Kobayashi K. A lean man with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 5 (2007) A32
14. Yazaki M., Hashikura Y., Takei Y., Ikegami T., Miyagawa S., Yamamoto K., et al. Feasibility of auxiliary partial orthotopic liver transplantation from living donors for patients with adult-onset type II citrullinemia. Liver Transpl 10 (2004) 550-554
15. Takagi H., Hagiwara S., Hashizume H., Kanda D., Sato K., Sohara N., et al. Adult onset type II citrullinemia as a cause of non-alcoholic steatohepatitis. J Hepatol 44 (2006) 236-239
16. Kleiner D.E., Brunt E.M., Natta M.V., Behling C., Contos M.J., Cummings O.W., et al. Design and validation of histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005) 1313-1321
17. The Examination Committee of Criteria for 'Obesity Diseases' in Japan, Japan Society for the Study of Obesity. New Criteria for 'Obesity Disease' in Japan. Circ J 2002;66:987-992.
18. Tanaka N., Tanaka E., Sheena Y., Komatsu M., Okiyama W., Misawa N., et al. Useful parameters for distinguishing nonalcoholic steatohepatitis with mild steatosis from cryptogenic chronic hepatitis in the Japanese population. Liver Int 26 (2006) 956-963
19. Arai H., Yamamoto A., Matsuzawa Y., Saito Y., Yamada N., Oikawa S., et al. Prevalence of metabolic syndrome in the general Japanese population in 2000. J Atheroscler Thromb 13 (2006) 202-208
20. Su T.S., Bock H.G., Beaudet A.L., and O'Brien W.E. Molecular analysis of argininosuccinate synthetase deficiency in human fibroblasts. J Clin Invest 70 (1982) 1334-1339
21. Tanaka N., Sano K., Horiuchi A., Tanaka E., Kiyosawa K., and Aoyama T. Highly-purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol 42 (2008) 413-418
22. Saadeh S., Younossi Z.M., Remer E.M., Gramlich T., Ong J.P., Hurley M., et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123 (2002) 745-750
23. Yasuda T., Yamaguchi N., Kobayashi K., Nishi I., Horinouchi H., Jalil M.A., et al. Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinemia. Hum Genet 107 (2000) 537-545
24. Yamaguchi N., Kobayashi K., Yasuda T., Nishi I., Iijima M., Nakagawa M., et al. Screening of SLC25A13 mutations in early and late onset patients with citrin deficiency and in the Japanese population: identification of two novel mutations and establishment of multiple DNA diagnosis methods for nine mutations. Hum Mutat 19 (2002) 122-130
25. Takaya J., Kobayashi K., Ohashi A., Ushikai M., Tabata A., Fujimoto S., et al. Variant clinical courses of 2 patients with neonatal intrahepatic cholestasis who have a novel mutation of SLC25A13. Metabolism 54 (2005) 1615-1619
26. Ohura T., Kobayashi K., Tazawa Y., Abukawa D., Sakamoto O., Tsuchiya S., et al. Clinical pictures of 75 patients with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD). J Inherit Metab Dis 30 (2007) 139-144
27. Soeda J, Yazaki M, Nakata T, Miwa S, Ikeda S, Hosoda W, et al. Primary liver carcinoma exhibiting dual hepatocellular-biliary epithelial differentiations associated with citrin deficiency: a case report and review of the literature. J Clin Gastroenterol, in press.
28. Kobayashi K., Shaheen N., Kumashiro R., Tanikawa K., O'Brien W.E., Beaudet A.L., et al. A search for primary abnormality in adult-onset type II citrullinemia. Am J Hum Genet 53 (1993) 1024-1030
29. Inui Y., Kuwajima M., Kawata S., Fukuda K., Maeda Y., Igura T., et al. Impaired ketogenesis in patients with adult-type citrullinemia. Gastroenterology 107 (1994) 1154-1161
30. Aoyama T., Peters J.M., Iritani N., Nakajima T., Furihata K., Hashimoto T., et al. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα). J Biol Chem 273 (1998) 5678-5684
31. Tanaka N., Moriya K., Kiyosawa K., Koike K., Gonzalez F.J., and Aoyama T. PPARα activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice. J Clin Invest 118 (2008) 683-694
32. Ikeda S., Kawa S., Takei Y., Yamamoto K., Shimojo H., Tabata K., et al. Chronic pancreatitis associated with adult-onset type II citrullinemia: clinical and pathologic findings. Ann Intern Med 141 (2004) W109-W110
33. Tanaka N., Horiuchi A., Yokoyama T., Kawa S., and Kiyosawa K. Pancreatic exocrine insufficiency: a rare cause of nonalcoholic steatohepatitis. Am J Gastroenterol 103 (2008) 245-246
34. Ikeda S., Yazaki M., Takei Y., Ikegami T., Hashikura T., Kawasaki S., et al. Type II (adult onset) citrullinaemia: clinical pictures and the therapeutic effect of liver transplantation. J Neurol Neurosurg Psychiatry 71 (2001) 663-670
35. Imamura Y., Kobayashi K., Shibatou T., Aburada S., Tahara K., Kubozono O., et al. Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: a case report of siblings showing homozygous SLC25A13 mutation with and without the disease. Hepatol Res 26 (2003) 68-72
36. Kobayashi K., Horiuchi M., and Saheki T. Pancreatic secretory trypsin inhibitor as a diagnostic marker for adult-onset type II citrullinemia. Hepatology 25 (1997) 1160-1165
37. Tsuboi Y., Fujino Y., Kobayashi K., Saheki T., and Yamada T. High serum pancreatic secretory trypsin inhibitor before onset of type II citrullinemia. Neurology 57 (2001) 933
38. Tanaka T., Nagao M., and Tsutsumi H. Application of mutation analysis for the previously uncertain cases of adult-onset type II citrullinemia (CTLN2) and their clinical profiles. Tohoku J Exp Med 198 (2002) 89-97
39. Hagiwara N., Sekijima Y., Takei Y., Ikeda S., Kawasaki S., Kobayashi K., et al. Hepatocellular carcinoma in a case of adult-onset type II citrullinemia. Intern Med 42 (2003) 978-982
40. Tsai C.W., Yang C.C., Chen H.L., Hwu W.L., Wu M.Z., Liu K.L., et al. Homozygous SLC25A13 mutation in a Taiwanese patient with adult-onset citrullinemia complicated with steatosis and hepatocellular carcinoma. J Formos Med Assoc 105 (2006) 852-856
41. Tokuhara D., Iijima M., Tamamori A., Ohura T., Takaya J., Maisawa S., et al. Novel diagnostic approach to citrin deficiency: analysis of citrin protein in lymphocytes. Mol Genet Metab 90 (2007) 30-36
42. Moriyama M., Li M.X., Kobayashi K., Sinasac D.S., Kannan Y., Iijima M., et al. Pyruvate ameliorates the defect in ureogenesis from ammonia in citrin-deficient mice. J Hepatol 44 (2006) 930-938